three from government and seven from the pharmaceutical sector, triangulated against the literature.

So really Between Leadership and Dependence is the title of my thesis or dissertation and that was really looking at kind of Australia's position in the life sciences sector, which I think is really interesting because Australia has this role as kind of and a cost effectiveness kind of leader, policy leader in that space.

But they're also a beneficiary of the kind of global innovation that goes on and there's a dual kind of dependency on both.

And I really wanted to understand what were the impact of that kind of role sitting in between of both of those on patient access and on innovation and new medications that might be available.

To do that, I had a series of interviews and I'll go through the kind of method and approach in just a moment.

But before I do, I just wanted to...

Make sure to disclaimer that this research was very much carried out independently of my current job at New South Wales Health.

What you are listening for is the strength of each theme and which side of the table it came from.